UBS Group’s MiNK Therapeutics INKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1K | Hold |
284
| – | – | ﹤0.01% | 8195 |
|
|
2025
Q1 | $2.45K | Sell |
284
-1
| -0.4% | -$9 | ﹤0.01% | 8012 |
|
|
2024
Q4 | $1.98K | Sell |
285
-336
| -54% | -$2.34K | ﹤0.01% | 7880 |
|
|
2024
Q3 | $4.66K | Buy |
621
+299
| +93% | +$2.24K | ﹤0.01% | 6922 |
|
|
2024
Q2 | $3.06K | Sell |
322
-1
| -0.3% | -$9 | ﹤0.01% | 7101 |
|
|
2024
Q1 | $2.94K | Sell |
323
-182
| -36% | -$1.65K | ﹤0.01% | 6632 |
|
|
2023
Q4 | $5.4K | Buy |
505
+150
| +42% | +$1.6K | ﹤0.01% | 6579 |
|
|
2023
Q3 | $3.9K | Buy |
355
+40
| +13% | +$440 | ﹤0.01% | 6357 |
|
|
2023
Q2 | $6.62K | Buy |
315
+130
| +70% | +$2.73K | ﹤0.01% | 6273 |
|
|
2023
Q1 | $3.51K | Sell |
185
-65
| -26% | -$1.23K | ﹤0.01% | 7214 |
|
|
2022
Q4 | $6.54K | Buy |
250
+224
| +862% | +$5.86K | ﹤0.01% | 7829 |
|
|
2022
Q3 | $1K | Hold |
26
| – | – | ﹤0.01% | 8861 |
|
|
2022
Q2 | $0 | Sell |
26
-510
| -95% | – | ﹤0.01% | 9472 |
|
|
2022
Q1 | $12K | Buy |
536
+143
| +36% | +$3.2K | ﹤0.01% | 7131 |
|
|
2021
Q4 | $18K | Buy |
+393
| New | +$18K | ﹤0.01% | 6858 |
|